title: End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis.
abstract: Background.  Cryptococcosis in the setting of end-stage liver disease (ESLD) has been associated with high mortality. We sought to compare the outcome of cryptococcal disease in patients with ESLD to that of human immunodeficiency virus (HIV)-positive patients and to those patients without HIV or ESLD. Methods.  We assembled a retrospective cohort of 232 consecutive cases of cryptococcosis in our institution, from 2002 to 2014, inclusively. We analyzed the cases for comorbidities, type of infection, and survival. Data were analyzed with t tests, Fishers Exact test, and Kaplan-Meyer analysis. Results.  Twenty-five (10.8%) patients with cryptococcal infection had concomitant ESLD; of these, 5 (20%) presented with peritonitis. Most (17 of 25, 68%) did not have any other cause of immunocompromise that has been more classically associated with cryptococcosis. Patients with ESLD had a significantly higher mortality than HIV-positive patients and HIV-negative patients without ESLD (HIVNE) (80% vs 13.6% and 22.7%, respectively; P < .001). In addition, fatal outcome in ESLD patients occurred more rapidly than in HIVNE patients, with a median survival of 6 days (vs 17), despite a comparable time to diagnosis (6.2 vs 6.6 days). Conclusions.  Cryptococcosis is an important morbidity in patients with ESLD. Patients with ESLD who are infected with Cryptococcus have a high and rapid mortality. This suggests that a high level of vigilance for cryptococcal infection should be kept in patients with ESLD.
authors.affiliation: Division of Infectious Diseases, Department of Medicine , Washington University School of Medicine , and.
authors.forename: Andrej
authors.initials: A
authors.lastname: Spec
authors.affiliation: Department of Medicine , St. Lukes Hospital , St. Louis, Missouri.
authors.forename: Krunal
authors.initials: K
authors.lastname: Raval
authors.affiliation: Division of Infectious Diseases, Department of Medicine , Washington University School of Medicine , and.
authors.forename: William G
authors.initials: WG
authors.lastname: Powderly
keywords: Cryptococcus; adult; end-stage live disease (ESLD); prognosis
references.citation: Clin Gastroenterol Hepatol. 2011 Sep;9(9):727-38
references.pmid: 21397731
references.citation: Int J Infect Dis. 2014 Mar;20:31-6
references.pmid: 24440644
references.citation: AIDS. 2009 Feb 20;23(4):525-30
references.pmid: 19182676
references.citation: Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):937-43
references.pmid: 18449582
references.citation: J Infect Dis. 2007 Mar 1;195(5):756-64
references.pmid: 17262720
references.citation: Neuropatol Pol. 1967 Jul-Sep;5(3):287-96
references.pmid: 6077954
references.citation: Drugs. 2013 May;73(6):495-504
references.pmid: 23575940
references.citation: J Hepatol. 1986;2(2):195-207
references.pmid: 2937833
references.citation: PLoS One. 2015 Mar 06;10(3):e0119090
references.pmid: 25747471
references.citation: Transplantation. 2015 Oct;99(10):2132-41
references.pmid: 25806406
references.citation: Clin Exp Immunol. 1971 May;8(5):749-60
references.pmid: 5581064
references.citation: Best Pract Res Clin Gastroenterol. 2007;21(1):77-93
references.pmid: 17223498
references.citation: Eur J Clin Microbiol Infect Dis. 2008 Apr;27(4):307-10
references.pmid: 18157678
references.citation: Jpn J Infect Dis. 2008 Mar;61(2):111-5
references.pmid: 18362398
references.citation: Medicine (Baltimore). 2004 May;83(3):188-92
references.pmid: 15118545
references.citation: Transplantation. 2005 Oct 27;80(8):1131-3
references.pmid: 16278598
references.citation: PLoS One. 2013;8(2):e56269
references.pmid: 23457543
references.citation: PLoS One. 2013;8(3):e60431
references.pmid: 23555970